The Prevalence and Negative Impacts of Substance Use Disorders among People with HIV in the United States: A Real-Time Delphi Survey of Key Stakeholders
Authors:
- Bryan R. GarnerBGBryan R. Garner
- Heather J. GothamHGHeather J. Gotham
- Hannah K. KnudsenHKHannah K. Knudsen
- Brittany A. ZulkiewiczBZBrittany A. Zulkiewicz
- Stephen J. TuellerSTStephen J. Tueller
- Marcus BerzofskyMBMarcus Berzofsky
- Tom DonohoeTDTom Donohoe
- Erika G. MartinEMErika G. Martin
- L. Lauren BrownLBL. Lauren Brown
- Theodore GordonTGTheodore Gordon
Open Access
- 29 September 2021
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 26 (4) , 1183-1196
Abstract
Although HIV and substance use disorders (SUDs) constitute a health syndemic, no research to date has examined the perceived negative impacts of different SUDs for people with HIV (PWH). In May 2019, 643 stakeholders in the U.S., representing clients of AIDS service organizations (ASOs), ASO staff, and HIV/AIDS Planning Council members, participated in an innovative Stakeholder-Engaged Real-Time Delphi (SE-RTD) survey focused on the prevalence and individual-level negative impact of five SUDs for PWH. The SE-RTD method has advantages over conventional survey methods by efficiently sharing information, thereby reducing the likelihood that between-group differences are simply due to lack of information, knowledge, and/or understanding. The population-level negative impacts were calculated by weighting each SUD’s individual-level negative impact on indicators of the HIV Care Continuum and other important areas of life by the perceived prevalence of each SUD. Overall, we found these SUDs to have the greatest population-level negative impact scores (possible range 0–24): alcohol use disorder (population-level negative impact = 6.9; perceived prevalence = 41.9%), methamphetamine use disorder (population-level negative impact = 6.5; perceived prevalence = 3.2%), and opioid use disorder (population-level negative impact = 6.4; perceived prevalence = 34.6%). Beyond further demonstration of the need to better integrate SUD services within HIV settings, our findings may help inform how finite funding is allocated for addressing the HIV-SUD syndemic within the U.S. Based on our findings, such future efforts should prioritize the integration of evidence-based treatments that help address use disorders for alcohol, methamphetamine, and opioids.Keywords
Funding Information
- National Institute on Drug Abuse (R01DA044051)
This publication has 47 references indexed in Scilit:
- Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experienceSexually Transmitted Infections, 2011
- The Urgency Of Providing Comprehensive And Integrated Treatment For Substance Abusers With HIVHealth Affairs, 2011
- The Spectrum of Engagement in HIV Care and its Relevance to Test-and-Treat Strategies for Prevention of HIV InfectionClinical Infectious Diseases, 2011
- A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilizationDrug and Alcohol Dependence, 2010
- The Reinforcing Therapist Performance (RTP) experiment: Study protocol for a cluster randomized trialImplementation Science, 2010
- Alcohol Use and Antiretroviral Adherence: Review and Meta-AnalysisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Public Perceptions of Substance Abuse and How Problems Are Resolved: Implications for Medical and Public Health ServicesSouthern Medical Journal, 2008
- Prevalence and Comorbidity of Psychiatric Diagnoses Based on Reference Standard in an HIV+ Patient PopulationPsychosomatic Medicine, 2008
- Factors Associated with HIV Viral Load in a Respondent Driven Sample in Los AngelesAIDS and Behavior, 2007
- Impact of Active Drug Use on Antiretroviral Therapy Adherence and Viral Suppression in HIV-infected Drug UsersJournal of General Internal Medicine, 2002